Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Eye-tracking tests may help identify people at high risk of developing Alzheimer's disease

New research has found that it may be possible to predict if people with mild memory and thinking impairments will go onto develop Alzheimer's disease using eye-tracking technology.

23 Aug 2019

Finding innovative treatments to help patients with traumatic brain injury

To treat a traumatic brain injury, researchers are thinking outside the box.

22 Aug 2019

RNA sequencing data added to robust study of Parkinson's disease

A team at the Keck School of Medicine of USC, in collaboration with The Michael J. Fox Foundation for Parkinson's Research, has just added a crucial new element - RNA sequencing data -- to its robust study of Parkinson's disease.

22 Aug 2019

BU researcher receives NIH grant to study childhood adversity and later life health outcomes

Lewina Lee, PhD, assistant professor of psychiatry at Boston University School of Medicine and clinical research psychologist at the National Center for PTSD at VA Boston, has received a five-year, $3.5 million R01 grant from the National Institutes of Health's National Institute on Aging to establish the Boston Early Adversity and Mortality Study.

22 Aug 2019

UCI study finds link between brain immune cells and Alzheimer's disease development

Scientists from the University of California, Irvine School of Biological Sciences have discovered how to forestall Alzheimer's disease in a laboratory setting, a finding that could one day help in devising targeted drugs that prevent it.

21 Aug 2019

Poor handgrip may be a sign of impaired cognition and memory in older Americans

For older Americans, poor handgrip may be a sign of impaired cognition and memory, a new study suggests.

21 Aug 2019

Alzheimer’s Research UK launches new survey to help shape future treatments for dementia

Alzheimer’s Research UK, the UK’s leading dementia research charity, is asking people to take part in a new survey that could help shape future treatments for dementia.

21 Aug 2019

Alzheimer's drug reverses brain damage in rats exposed to alcohol during adolescence

A drug used to slow cognitive decline in adults with Alzheimer's disease appears to reverse brain inflammation and neuron damage in rats exposed to alcohol during adolescence.

20 Aug 2019

UCLA scientists discover new insights that may lead to progress in fighting Alzheimer's disease

More than three decades of research on Alzheimer's disease have not produced any major treatment advances for those with the disorder, according to a UCLA expert who has studied the biochemistry of the brain and Alzheimer's for nearly 30 years.

20 Aug 2019

Loss of cells in the brain found to be associated with stuttering

Researchers believe that stuttering - a potentially lifelong and debilitating speech disorder - stems from problems with the circuits in the brain that control speech, but precisely how and where these problems occur is unknown.

19 Aug 2019

Northwestern scientists receive $3.1 million grant to investigate drug therapies for ALS

Two Northwestern University scientists have received a $3.1 million grant from the National Institute on Aging to collaborate and investigate drug therapies for amyotrophic lateral sclerosis.

18 Aug 2019

Regular exercise may reduce the risk of Alzheimer’s Disease

Regular exerciss may help prevent cognitive decline seen in neurodegenerative diseases such as Alzheimer’s.

16 Aug 2019

New AAN guidelines includes recommendations for treatment of migraine in children, teens

For children and teens with migraine, the pain and symptoms that accompany migraine attacks can be debilitating, resulting in missed school days, absence from social or sporting events, and affected home activities.

14 Aug 2019

New research reveals how our brain remembers the order of events

For centuries understanding how the order of events is stored in memory has been a mystery. However, researchers from the Department of Computer Science at the University of Warwick have worked out how the order of events in memory could be stored and later recalled in the hippocampal memory system in the brain.

14 Aug 2019

Study investigates association between migraine diagnoses and dementia

Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship.

14 Aug 2019

Nanotechnology could boost stem cell transplantation research

Nanotechnology developed at Rutgers University-New Brunswick could boost research on stem cell transplantation, which may help people with Alzheimer's disease, Parkinson's disease, other neurodegenerative diseases and central nervous system injuries.

14 Aug 2019

Alzheimer’s disease risk gene is involved in synaptic transmission

A study published today in the journal Cell Reports sheds new light on how the CD2AP gene may enhance Alzheimer's disease susceptibility.

14 Aug 2019

Beta amyloid structure mapped in new Alzheimer’s research

In search of a possible cure for Alzheimer’s disease (AD), scientists have found out the molecular structure of a type of protein called beta amyloid that accumulates within brain cells, eventually killing them. This could help understand how to prevent these abnormal proteins from forming, leading to a cure or treatment for this killer disease.

13 Aug 2019

New research suggests another possible mechanism for Alzheimer’s

Neurofibrillary plaques and tau protein are among the most widely known pathological entities characterizing Alzheimer’s disease (AD), but new research at the University of California, Riverside, has come up with another plausible explanation for this debilitating disorder.

13 Aug 2019

Tissue model of Alzheimer's mimics beta-amyloid's effects on blood-brain barrier

Beta-amyloid plaques, the protein aggregates that form in the brains of Alzheimer's patients, disrupt many brain functions and can kill neurons. They can also damage the blood-brain barrier — the normally tight border that prevents harmful molecules in the bloodstream from entering the brain.

13 Aug 2019

Alzheimer's Disease News and Research

Further Reading

Eye-tracking tests may help identify people at high risk of developing Alzheimer's disease

Finding innovative treatments to help patients with traumatic brain injury

RNA sequencing data added to robust study of Parkinson's disease

BU researcher receives NIH grant to study childhood adversity and later life health outcomes

UCI study finds link between brain immune cells and Alzheimer's disease development

Poor handgrip may be a sign of impaired cognition and memory in older Americans

Alzheimer’s Research UK launches new survey to help shape future treatments for dementia

Alzheimer's drug reverses brain damage in rats exposed to alcohol during adolescence

UCLA scientists discover new insights that may lead to progress in fighting Alzheimer's disease

Loss of cells in the brain found to be associated with stuttering

Northwestern scientists receive $3.1 million grant to investigate drug therapies for ALS

Regular exercise may reduce the risk of Alzheimer’s Disease

New AAN guidelines includes recommendations for treatment of migraine in children, teens

New research reveals how our brain remembers the order of events

Study investigates association between migraine diagnoses and dementia

Nanotechnology could boost stem cell transplantation research

Alzheimer’s disease risk gene is involved in synaptic transmission

Beta amyloid structure mapped in new Alzheimer’s research

New research suggests another possible mechanism for Alzheimer’s

Tissue model of Alzheimer's mimics beta-amyloid's effects on blood-brain barrier

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News